LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM D. J. Betteridge Pages: S149 - S151
Engineered cell lines for insulin replacement in diabetes: current status and future prospects C. B. NewgardS. ClarkK. Normington Pages: S42 - S47
Molecular basis and promise of genetic therapy for diabetic dyslipidaemia: studies in an animal model of diabetes L. ChanK. Kobayashi Pages: S155 - S156
Alternative insulin delivery systems: how demanding should the patient be? K. S. PolonskyM. M. ByrneJ. Sturis Pages: S97 - S101
Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues B. Williams Pages: S118 - S120
Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience M. HanefeldH. SchmechelThe DIS Group Pages: S123 - S124
Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues H. Yki-JärvinenS. Mäkimattila Pages: S141 - S144
Antihypertensive treatment and mortality in diabetic patients What is the evidence? P. T. SawickiT. HeiseM. Berger Pages: S134 - S137
The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB A. D. SnidermanK. CianfloneK. Frayn Pages: S152 - S154
Pharmacological reversal of advanced glycation end-product-mediated protein crosslinking P. UlrichX. Zhang Pages: S157 - S159
Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers B. Zinman Pages: S88 - S90
Inflammation in the vascular wall as an early event in atherosclerosis S. M. PrescottG. A. ZimmermanD. M. Stafforini Pages: S111 - S112
Advances and prospects in glucose assay technology D. A. GoughJ. C. ArmourD. A. Baker Pages: S102 - S107
Cytosolic NADH/NAD+ , free radicals, and vascular dysfunction in early diabetes mellitus Y. IdoC. KiloJ. R. Williamson Pages: S115 - S117
Coronary heart disease and risk factors in NIDDM – experience from the United Kingdom Prospective Diabetes Study R. C. TurnerH. MillnsR. R. Holman Pages: S121 - S122
Influence of diabetes mellitus on the heart and macrovascular mortality E. StandlO. SchnellM. Haslbeck Pages: S125 - S126
Impaired glucose tolerance – is it relevant for cardiovascular disease? S. M. Haffner Pages: S138 - S140
Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: effects of inhibiting protein phosphatases and the p70S6K signalling pathway T.-A. LinJ. C. Lawrence Jr. Pages: S18 - S24
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor D. Ish-ShalomC. T. ChristoffersenP. De Meyts Pages: S25 - S31
Signal transduction mechanisms in nutrient-induced insulin secretion M. PrentkiK. TornheimB. E. Corkey Pages: S32 - S41
Modifications in the B10 and B26–30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor L. J. SliekerG. S. BrookeR. E. Chance Pages: S54 - S61
Microdialysis techniques in the study of brain and skeletal muscle D. G. MaggsW. P. BorgR. S. Sherwin Pages: S75 - S82
Are presently available insulin analogues clinically beneficial? M. BergerL. Heinemann Pages: S91 - S96
